These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29498104)

  • 1. Cardio-hepatic risk assessment by CMR imaging in liver transplant candidates.
    Reddy ST; Thai NL; Oliva J; Tom KB; Dishart MK; Doyle M; Yamrozik JA; Williams RB; Shah M; Wani A; Singh A; Maheswary R; Biederman RWW
    Clin Transplant; 2018 May; 32(5):e13229. PubMed ID: 29498104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory use of cardiovascular magnetic resonance imaging in liver transplantation: a one-stop shop for preoperative cardiohepatic evaluation.
    Reddy ST; Thai NL; Fakhri AA; Oliva J; Tom KB; Dishart MK; Doyle M; Yamrozik JA; Williams RB; Grant SB; Poydence J; Shah M; Singh A; Nathan S; Biederman RW
    Transplantation; 2013 Nov; 96(9):827-33. PubMed ID: 23982342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inexplicable Outcome of Early Appearance of Hepatocellular Carcinoma in the Allograft After Deceased Donor Liver Transplantation: A Case Report.
    Navarro Burgos JB; Lee KW; Shin YC; Lee DS; Lee KB; Yi NJ; Suh KS
    Transplant Proc; 2015 Dec; 47(10):3012-5. PubMed ID: 26707329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
    Ladd LM; Tirkes T; Tann M; Agarwal DM; Johnson MS; Tahir B; Sandrasegaran K
    Clin Mol Hepatol; 2016 Dec; 22(4):450-457. PubMed ID: 27987537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No apparent benefit of preemptive sorafenib therapy in liver transplant recipients with advanced hepatocellular carcinoma on explant.
    Satapathy SK; Das K; Kocak M; Helmick RA; Eason JD; Nair SP; Vanatta JM
    Clin Transplant; 2018 May; 32(5):e13246. PubMed ID: 29577449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Cardiac Risk Assessment in Patients Undergoing Liver Transplant Due to Hepatocellular Carcinoma: Should It Be Different?
    Muderrisoglu H; Yilmaz KC; Karacaglar E; Bal U; Aydinalp A; Moray G; Haberal M
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):65-68. PubMed ID: 28302002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
    Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It?
    Cascales-Campos P; Martinez-Insfran LA; Ramirez P; Ferreras D; Gonzalez-Sanchez MR; Sanchez-Bueno F; Robles R; Pons JA; Capel A; Parrilla P
    Transplant Proc; 2018 Mar; 50(2):591-594. PubMed ID: 29579861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation.
    Welling TH; Eddinger K; Carrier K; Zhu D; Kleaveland T; Moore DE; Schaubel DE; Abt PL
    Liver Transpl; 2018 Sep; 24(9):1233-1242. PubMed ID: 29729113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
    Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified magnetic resonance angiography of the liver using sensitivity encoding in comparison with digital subtraction angiography and CT arterial portography.
    Yan SX; Liang TB; Fujii M; Kawamitsu H; Sugimura K; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):185-91. PubMed ID: 15908313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma and liver transplantation: a 12-year experience.
    Varona MA; Del Pino JM; Barrera M; Arranz J; Hernández BM; Perez HF; Padilla J; Fuentes JS; Aguirre A; Mendez S; Sanz P; Gianchandani R; Perera A; Soriano A
    Transplant Proc; 2009 Apr; 41(3):1005-8. PubMed ID: 19376411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.